Company / Revenue
IRONWOOD PHARMACEUTICALS INC Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$296.2M
FY2025
5-year range
$296.2M / $442.7M
FY2021-FY2025
Trend
-27.9%
vs FY2024
Sector context
#76 of 155
Health Care
What the data says
At $296M, IRONWOOD PHARMACEUTICALS INC's revenue ranks #76 of 155 in the Health Care sector. Revenue has fluctuated over the past 10 years, ranging from $52M in FY2017 to $443M in FY2023.
Based on SEC 10-K filings.
$296M in FY2025 with a 5-year CAGR of -3.1%.
Declined from $443M to $296M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Sector benchmark
#76 of 155 in Health CareTop 49% of 155This company $296.2M Sector average $4.5B
▼
-93.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2025, revenue decreased 27.9% year-over-year.
- Ranks #76 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $296.2M | -27.9% |
| FY2024 | $410.6M | -7.3% |
| FY2023 | $442.7M | +13.7% |
| FY2022 | $389.5M | -5.9% |
| FY2021 | $413.8M | +19.4% |
| FY2020 | $346.6M | -19.1% |
| FY2019 | $428.4M | +56.4% |
| FY2018 | $274.0M | +425.2% |
| FY2017 | $52.2M | -81.0% |
| FY2016 | $274.0M | +83.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026